These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3015004)

  • 1. Leakage of periplasmic proteins from Escherichia coli mediated by polymyxin B nonapeptide.
    Dixon RA; Chopra I
    Antimicrob Agents Chemother; 1986 May; 29(5):781-8. PubMed ID: 3015004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymyxin B and polymyxin B nonapeptide alter cytoplasmic membrane permeability in Escherichia coli.
    Dixon RA; Chopra I
    J Antimicrob Chemother; 1986 Nov; 18(5):557-63. PubMed ID: 3027012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of polymyxin B nonapeptide (PMBN) on transformation.
    Viljanen P
    Biochem Biophys Res Commun; 1987 Mar; 143(3):923-7. PubMed ID: 3032189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of polymyxin B nonapeptide on Aeromonas salmonicida.
    McCashion RN; Lynch WH
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1414-9. PubMed ID: 2823698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the cell envelope in the antibacterial activities of polymyxin B and polymyxin B nonapeptide against Escherichia coli.
    Sahalan AZ; Dixon RA
    Int J Antimicrob Agents; 2008 Mar; 31(3):224-7. PubMed ID: 18083010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymyxin B nonapeptide potentiates the eradication of Gram-negative bacterial persisters.
    Kim SJ; Jo J; Kim J; Ko KS; Lee W
    Microbiol Spectr; 2024 Apr; 12(4):e0368723. PubMed ID: 38391225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The outer membrane permeability-increasing action of linear analogues of polymyxin B nonapeptide.
    Vaara M
    Drugs Exp Clin Res; 1991; 17(9):437-43. PubMed ID: 1822436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The outer membrane permeability-increasing action of deacylpolymyxins.
    Viljanen P; Matsunaga H; Kimura Y; Vaara M
    J Antibiot (Tokyo); 1991 May; 44(5):517-23. PubMed ID: 1648055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycations which disorganize the outer membrane inhibit conjugation in Escherichia coli.
    Viljanen P
    J Antibiot (Tokyo); 1987 Jun; 40(6):882-6. PubMed ID: 3038818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of polymyxin B nonapeptide to gram-negative bacteria.
    Vaara M; Viljanen P
    Antimicrob Agents Chemother; 1985 Apr; 27(4):548-54. PubMed ID: 2988430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane-disorganizing property of polymyxin B nonapeptide.
    Lam C; Hildebrandt J; Schütze E; Wenzel AF
    J Antimicrob Chemother; 1986 Jul; 18(1):9-15. PubMed ID: 3019982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function studies of polymyxin B nonapeptide: implications to sensitization of gram-negative bacteria.
    Tsubery H; Ofek I; Cohen S; Fridkin M
    J Med Chem; 2000 Aug; 43(16):3085-92. PubMed ID: 10956216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An outer membrane-disorganizing peptide PMBN sensitizes E. coli strains to serum bactericidal action.
    Vaara M; Viljanen P; Vaara T; Mäkelä PH
    J Immunol; 1984 May; 132(5):2582-9. PubMed ID: 6325539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the hydrophobic domain of polymyxin B nonapeptide: effect on outer-membrane permeabilization and lipopolysaccharide neutralization.
    Tsubery H; Ofek I; Cohen S; Eisenstein M; Fridkin M
    Mol Pharmacol; 2002 Nov; 62(5):1036-42. PubMed ID: 12391265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A method for increasing electroporation competence of Gram-negative clinical isolates by polymyxin B nonapeptide.
    Qin J; Hong Y; Pullela K; Morona R; Henderson IR; Totsika M
    Sci Rep; 2022 Jul; 12(1):11629. PubMed ID: 35804085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of K88ab-mediated haemagglutination by polymyxin B nonapeptide.
    Matranga AM; Moore B; Bennett PM; Chopra I
    J Antimicrob Chemother; 1991 Nov; 28(5):655-62. PubMed ID: 1685733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shigella dysenteriae 1 cytotoxin: periplasmic protein releasable by polymyxin B and osmotic shock.
    Donohue-Rolfe A; Keusch GT
    Infect Immun; 1983 Jan; 39(1):270-4. PubMed ID: 6295958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manipulation of intracellular magnesium content in polymyxin B nonapeptide-sensitized Escherichia coli by ionophore A23187.
    Alatossava T; Jütte H; Kuhn A; Kellenberger E
    J Bacteriol; 1985 Apr; 162(1):413-9. PubMed ID: 2984182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of polymyxin B nonapeptide with anionic phospholipids.
    Kubesch P; Boggs J; Luciano L; Maass G; Tümmler B
    Biochemistry; 1987 Apr; 26(8):2139-49. PubMed ID: 3040082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting lipopolysaccharides by the nontoxic polymyxin B nonapeptide sensitizes resistant Escherichia coli to the bactericidal effect of human neutrophils.
    Rose F; Heuer KU; Sibelius U; Hombach-Klonisch S; Kiss L; Seeger W; Grimminger F
    J Infect Dis; 2000 Jul; 182(1):191-9. PubMed ID: 10882597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.